Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 3/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | PTGES | O14684 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.41 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27166243 | 0.89 | ACACB (0.43) | ITGB3ITGA2BPPARGPPARAACACB | |
| SCHEMBL27166240 | 0.88 | ITGB3 (0.41) | ITGB3ITGA2BPPARGPPARAACACB | |
| SCHEMBL25185955 | 0.84 | PPARG (0.39) | ITGB3ITGA2BPPARGPPARAPPARD | |
| SCHEMBL27166271 | 0.84 | CTSS (0.43) | ITGA4 | |
| SCHEMBL10604721 | 0.84 | CTSS (0.43) | ITGA4 | |
| SCHEMBL10957808 | 0.84 | ATM (0.42) | PPARGPPARAITGA4LMNAL3MBTL1 | |
| SCHEMBL10957821 | 0.84 | ATM (0.42) | PPARGPPARAITGA4LMNAL3MBTL1 | |
| SCHEMBL23099848 | 0.84 | ATM (0.42) | PPARGPPARAITGA4LMNAL3MBTL1 | |
| SCHEMBL25178617 | 0.83 | PPARA (0.42) | PPARGPPARALMNA | |
| SCHEMBL6140276 | 0.83 | HDAC3 (0.34) | ITGB3ITGA2BPPARGPPARAITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |